High Prevalence of Skin Disorders among HTLV-1\ud
Infected Individuals Independent of Clinical Status by Okajima, Renata Mie Oyama et al.
High Prevalence of Skin Disorders among HTLV-1
Infected Individuals Independent of Clinical Status
Renata Okajima1,2, Augusto C. P. Oliveira1, Jerusa Smid1, Jorge Casseb1,3"*, Jose Antonio Sanches, Jr.2"
1HTLV-Outpatient Clinic, Institute of Infectious Diseases ‘‘Emilio Ribas,’’ Sa˜o Paulo, Brazil, 2Department of Dermatology, University of Sa˜o Paulo Medical School, Sa˜o
Paulo, Brazil, 3 Institute of Tropical Medicine of Sa˜o Paulo, Laboratory of Medical Investigation 56 (LIM56), University of Sa˜o Paulo Medical School, Sa˜o Paulo, Brazil
Abstract
Background: Human T-cell lymphotropic virus type 1 (HTLV-1) infection can increase the risk of developing skin disorders.
This study evaluated the correlation between HTLV-1 proviral load and CD4+ and CD8+ T cells count among HTLV-1 infected
individuals, with or without skin disorders (SD) associated with HTLV-1 infection [SD-HTLV-1: xerosis/ichthyosis, seborrheic
dermatitis or infective dermatitis associated to HTLV-1 (IDH)].
Methods: A total of 193 HTLV-1-infected subjects underwent an interview, dermatological examination, initial HTLV-1
proviral load assay, CD4+ and CD8+ T cells count, and lymphproliferation assay (LPA).
Results: A total of 147 patients had an abnormal skin condition; 116 (79%) of them also had SD-HTLV-1 and 21% had other
dermatological diagnoses. The most prevalent SD-HTLV-1 was xerosis/acquired ichthyosis (48%), followed by seborrheic
dermatitis (28%). Patients with SD-HTLV-1 were older (51 vs. 47 years), had a higher prevalence of myelopathy/tropical
spastic paraparesis (HAM/TSP) (75%), and had an increased first HTLV-1 proviral load and basal LPA compared with patients
without SD-HTLV-1. When excluding HAM/TSP patients, the first HTLV-1 proviral load of SD-HTLV-1 individuals remains
higher than no SD-HTLV-1 patients.
Conclusions: There was a high prevalence of skin disorders (76%) among HTLV-1-infected individuals, regardless of clinical
status, and 60% of these diseases are considered skin disease associated with HTLV-1 infection.
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Introduction
Adult T-cell leukemia/lymphoma (ATLL), HTLV-1-associated
myelopathy/tropical spastic paraparesis (HAM/TSP) and infec-
tive dermatitis associated with HTLV-1 (IDH) are the main
diseases caused by human T-cell lymphotropic virus type 1
(HTLV-1) infection [1–3]. However, several other clinical
conditions have been associated with this viral infection, such as
uveitis, thyroiditis, arthritis and polymyositis [4–6].
There are an estimated 5 to 10 million HTLV-1 infected
individuals worldwide and Brazil is considered a highly endemic
area for HTLV-1 infection, with the largest absolute number of
HTLV-1 infected individuals, with more than one million people
living with this virus [7–9]. Despite this high prevalence, only a few
studies on the dermatological aspects of HTLV-1 infection have
been described in this country [10].
There is a lack of surrogate markers to assess the infected
patients who have a higher risk for HTLV-1 associated skin
disorders. Moreover, there are few immunological studies
among HTLV-1-infected persons who are simultaneously
suffering from HAM/TSP and skin diseases. The aim of this
study is to evaluate the prevalence of skin disorders in HTLV-1-
infected individuals and to correlate this prevalence with the
initial HTLV-1 proviral load, and initial CD4+ and CD8+T cell
count.
Materials and Methods
In the last 18 years, a cohort of HTLV-infected subjects has
been followed in the HTLV-outpatient clinic at the Institute of
Infectious Diseases ‘‘Emilio Ribas’’ (IIER), with the support of
nurses, nutritionists and physical therapists. From a total 450
HTLV-1-infected individuals, including asymptomatic carriers
and HAM/TSP patients, 193 of them were consecutively
evaluated for skin disorders from January 2008 to July 2010 by
the same dermatologist, blinded for the clinical status to minimize
information bias. Demographical and clinical dates were collected,
and dermatological examinations were carried out. The HIV co-
infected individuals were excluded, but HCV co-infected subjects
were included.
Ethics Statement: Written informed consent was obtained from
all participants, and the IIER ethical board approved the protocol.
The patients underwent laboratory studies, including HTLV-1
serological diagnosis, initial CD4+ and CD8+T cell counts, and an
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initial HTLV-1 proviral load. In accordance with previous studies,
the following skin disorders associated with HTLV-1 infection
(SD-HTLV-1) were considered: xerosis/acquired ichthyosis, seb-
orrheic dermatitis and infective dermatitis associated with HTLV-
1 (IDH) [1,10–12]. HAM/TSP was diagnosed according to
previously established criteria [13]. Skin culture and punch skin
biopsies were performed when clinical examination was not
sufficient for a dermatological diagnosis. Antibodies to HTLV-1/2
were detected by a diagnostic enzyme-linked immunosorbent
assay (ELISA) and confirmed by Western blot analysis and
polymerase chain reaction (PCR), which are capable of discrim-
inating between HTLV-1 and HTLV-2 [14]. To determine the
counts of CD4+ and CD8+ T-cell subsets, fresh whole blood
specimens were collected in EDTA tubes and subjected to flow
cytometry (Coulter EPICSH XL-MCLOˆ Flow Cytometer -
Beckman Coulter, Fullerton, CA), using human monoclonal
antibodies anti-CD3, anti-CD4, and anti-CD8, labeled with
fluorochrome.
The results of the first HTLV-1 proviral load were available in
the database. Quantitative proviral DNA levels were detected by a
real-time automated PCR method, using TaqMan probes for the
pol gene. The albumin gene served as the internal genomic control,
and MT2 cells were used as a positive control. The results are
reported as copies/10000 PBMCs, and the detection limit was 10
copies [15].
Data were analyzed using SPSS 17.0 software. The association
between independent variables and the outcome was analyzed
either by Student’s t-test or ANOVA (normal distribution
variables), or by Mann-Whitney test (non-normal distribution
variables), while the association between categorical variables and
the outcome was assessed by the X2 test. HTLV-1 proviral load
was log-transformed to obtain a normal distribution. Correlations
between HTLV-1 proviral load and SD-HTLV were performed
using Spearman’s rank correlation. Data are expressed as mean 6
standard deviation (normal distribution variables) or median and
interquartile range (non-normal distribution variables). Statistical
significance was set at a p value,0.05.
Results
One hundred ninety-three HTLV-1-infected subjects (43% of
all HTLV-1-infected patients at the HTLV outpatient clinic from
the Emilio Ribas Institute cohort) underwent a dermatological
exam. Mean age of patients was 49.4612.3 years. Female
gender had a higher prevalence of HTLV-1 infection (72%).
Regarding the presence of neurological involvement, 38% of the
patients had a diagnosis of HAM/TSP. The dermatological
examination revealed a high prevalence of skin disorders among
the HTLV-1-infected patients (76%). Sixty-five individuals
(34%) had one dermatological condition, and 42% (n= 81) of
the patients had two or more dermatological conditions. Among
the 147 patients that had an abnormal skin condition, 79%
(n= 116) had a skin disorder associated with HTLV-1 infection
(SD-HTLV-1) (xerosis/ichthyosis or seborrheic dermatitis) and
21% (n = 31) had other dermatological diagnoses. The most
prevalent skin disorder associated with an HTLV-1 diagnosis
was xerosis/ichthyosis (48%), followed by seborrheic dermatitis
(28%).
Table 1 shows the prevalence of skin disorders in the HTLV-1
patients based on a diagnosis of HAM/TSP or asymptomatic
carriers. SD-HTLV-1 were more prevalent on HAM/TSP
patients (xerosis/acquired ichthyosis (p = 0.007; seborrheic der-
matitis (p =,0.0001); IDH (p= 0.022). Patients with SD-HTLV-
1, including asymptomatic carriers and HAM/TSP, are older,
have a higher prevalence of HAM/TSP, and have a higher first
HTLV-1 proviral load (performed for 109 patients, p = 0.009),
compared with patients without SD-HTLV-1 (Table 2). Note that
75% of the SD-HTLV-1 group was made up of HAM/TSP
individuals.
Table 3 depicts the presence of SD-HTLV-1 in subjects that are
asymptomatic for neurological symptoms (absence of HAM/TSP).
Mean age of SD-HTLV-1 patients was 51 years, as compared with
44 years for HTLV-1 patients without SD (p= 0.002), regardless
of gender, CD4+ and CD8+ T cell counts (p = 0.489; p = 0.824).
The initial HTLV-1 proviral load was significantly higher for the
group with SD-HTLV-1 as compared with that for the group
without SD-HTLV-1 and asymptomatic for neurological symp-
toms (p= 0.021).
Discussion
Notably, 76% of the HTLV-1-infected asymptomatic carriers
and 88% of the HAM/TSP patients showed some skin disorder in
our study. These findings are similar to those described in two
previous studies involving asymptomatic carriers and HAM/TSP
subjects [10,12]. Thus, it is important to stress that HTLV-1
infection may have an etiological link to skin disease. In fact, skin
disorders are highly associated with HTLV-1 infection, regardless
of neurological symptoms, and they may represent a clinical
warning sign for the diagnosis or progression of this infection [10–
12].
Excluding HAM/TSP cases, subjects with a diagnosis of SD-
HTLV-1 are older than groups with other types of skin disorders
or individuals with a normal dermatological exam. However, no
significant association was observed with gender. These findings
suggest that older HTLV-1-infected individuals, who probably
have a longer duration of their viral infection have had more time
to develop SD-HTLV-1.
Although IDH is the only skin disease in which HTLV-1
infection is a criterion for diagnosis, other skin disorders could also
be associated with HTLV-1 infection, including xerosis/acquired
ichthyosis and seborrheic dermatitis, as previously demonstrated
[10–12,16]. In fact, in our study, these illnesses were the most
prevalent skin disorders associated with adult HTLV-1-infected
individuals, regardless of the clinical status. However, studies with
a longer follow-up should be performed to assess the hypothesis
that these skin manifestations are related to HTLV-1 infection.
The exact pathogenic mechanism of IDH still needs to be made
clear, but the current view is that a diagnosis of HTLV-1 infection
Author Summary
HTLV-1 infection may increase the risk of developing skin
disorders. A total of 193 HTLV-1 infected subjects were
studied, including asymptomatic carriers and HAM/TSP
patients. Of the subjects, 76% had an abnormal skin
condition, with a high prevalence both among HTLV-1
asymptomatic carriers and HAM/TSP patients. The most
prevalent SD-HTLV-1 was xerosis/acquired ichthyosis
(48%), followed by seborrheic dermatitis (28%). Patients
with SD-HTLV-1 were older (51 vs. 47 years), had a higher
prevalence of myelopathy/tropical spastic paraparesis
(HAM/TSP) (75%) and an increased first HTLV-1 proviral
load compared with patients without SD-HTLV-1. When
excluding HAM/TSP patients, the first HTLV-1 proviral load
of SD-HTLV-1 individuals remains higher than no SD-HTLV-
1 patients. Thus, skin diseases are highly prevalent among
HTLV-1-infected individuals.
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is necessary, leading in susceptible individuals to immune
deregulation, with subsequent immunosuppression and superin-
fection with Staphylococcus aureus and beta-haemolytic streptococci,
what additionally leads to chronic antigenic stimulation and
persistent inflammation of the skin. Genetic, host and environ-
mental factors have been shown to be associated [17].
Xerosis and acquired ichthyosis have been described as the
main dermatological manifestations associated with HAM/TSP
patients [11,12,18]. Xerosis is characterized by dryness of the skin,
and acquired ichthyosis is clinically characterized by cutaneous
xerosis and the formation of polygonal thin flat scales of varying
sizes, mainly on the extremities [19].
Acquired ichthyosis is a consequence of hypohydrosis that may
be secondary to the involvement of the autonomic nervous system,
affecting directly the HTLV-1-infected skin cells [12,20]. On the
basis of histopathological and immunohistochemical analyses of
skin fragments of acquired ichthyosis from HAM/TSP individuals,
it was concluded that keratinocytes are activated, probably as a
result of cytokines that are liberated from HTLV-1-infected
lymphocytes. This activation leads to an interference in keratino-
cyte differentiation and migration, resulting in a defect in the
processes of normal desquamation, accumulation and retention of
corneocytes [18]. We noticed that more than 50% of the SD-
HTLV-1 cases involved xerosis/acquired ichthyosis and decided
to include them in the same group because the acquired ichthyosis
showed a similar clinical dermatological pattern, comparable with
higher degree xerosis, and so they were clinically difficult to
differentiate [12].
HTLV-1 proviral load is a laboratorial risk marker for the
development of HAM/TSP and other diseases related to HTLV-1
infection [21,22]. The initial HTLV-1 proviral load was higher in
the group with SD-HTLV-1 (p= 0.009) as well as in the SD-
HTLV-1 HAM/TSP-free group (p = 0.021), both of which were
statistically significant. Although the proviral load may differ
greatly among individuals, it is relatively stable during the course
of the HTLV-1-related disease [23]. In HAM/TSP patients this
Table 1. Dermatological findings among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals (HAM/TSP and
asymptomatic carriers).
Dermatological findings HAM/TSP N (%)
HTLV-1 Asymptomatic
carriers N (%) p value
n=73 n=120
Xerosis/Acquired ichthyosis 44 (60.2) 51 (42.5) 0.006
Seborrheic dermatitis 35 (47.9) 18 (15.0) ,0.0001
Infestations 30 (41.1) 29 (24.1) 0.007
Contact dermatitis 1 (1.4) 3 (2.5) 0.619
Melasma 3 (4.1) 3 (2.5) 0.497
Infective dermatitis associated to HTLV-1 3 0 0.022
Other diagnoses 11 (15.0) 17 (14.1) 0.771
Normal findings on dermatological exam 9 (12.3) 37 (30.8) 0.005
HAM/TSP: HTLV-1-associated myelopathy/Tropical spastic paraparesis.
Infestations: Dermatophytosis (N: 55), Scabies (N;1), Pityriasis versicolor (N;3).
Other diseases: Herpes simplex (N: 4), Pytiriasis alba (N; 3), Cheilitis (N;3), Callosity (N: 2), Pressure ulcer (N:2), Verruca vulgaris (N:2); Vitiligo (N: 1), Photosensitivity (N: 1),
Hypertrichosis (n: 1), Neurofibromatosis (N;1), Insect bite reaction (N;1), Acanthosis nigricans (N:1), Lichen planus (N:1), Nummular dermatitis (N:1), Basal cell carcinoma
(N:1),, Epidermal cyst (N:1), Rhinophyma (N:1), Miliaria (N:1), Rosacea (N:1), Exogenous ochronosis (N:1), Venous ulcer (N:1), Folliculitis (N:1), Lymphoma (N:1),
Hyperkeratosis plantare (N:1), Keratosis pilaris (N:1), Erythrodermia (N:1), Folliculitis decalvans (N:1), Pyogenic granuloma (N:1), Livedo reticularis (N:1), Madarosis (N:1),
Erythema nodosum/Panniculitis (N:1), Molluscum contagiosum (N:1).
doi:10.1371/journal.pntd.0002546.t001
Table 2. Characteristics of patients according to the presence of dermatological diseases associated to HTLV-1 infection.
Variable
Skin disorder associated
to HTLV-1 (N=116)
No skin disorder
associated to HTLV-1
(N=77) p value
Age (years, mean, SD) 51612 47612 0.014
Female (%) 76 66 0.190
HCV coinfected (%) 13.9 14.3 1.000
Log10 HTLV-1 proviral load (copies/10
4 PBMCs, mean, SD) 2.3060.87* 1.7561.00** 0.009
T CD4 cells count (cells/mm3, median, interquartile range) 1033 (766–1298) 982 (817–1285) 0.91
T CD8 cells count (cells/mm3, median, interquartile range) 557 (386–756) 548 (441–726) 0.97
HAM/TSP (%) 75 25 0.002
HCV: Hepatitis C virus; SD: Standard deviation; Skin disorders associated to HTLV-1: xerosis/acquired ichthyosis and seborrheic dermatitis.
*N tested = 67 subjects,
**N. tested: 42 subjects.
doi:10.1371/journal.pntd.0002546.t002
Prevalence of Skin Disorders in HTLV-1 Patients
PLOS Neglected Tropical Diseases | www.plosntds.org 3 November 2013 | Volume 7 | Issue 11 | e2546
finding suggests that proviral load reaches a stable level
determined by the relationship between viral expression and the
immune response against the virus [23].
As previously shown, HTLV-1 was identified by PCR on skin
cells in addition to lymphocytes in HTLV-1-infected persons,
regardless of their clinical status 10. Because of these findings,
several authors believe that HTLV-1 can modify the function of
infected cells, resulting in skin disorders that are caused directly by
the presence of the virus in the infected cells [10,16,24]. Another
possible mechanism of skin disorders among HTLV-1-infected
individuals is the production of cytokines in HTLV-1-infected
lymphocytes, promoting a functional disturbance on skin cells
[18]. This lack of association may be explained by the presence of
HTLV-1 in specific sites that occur during HAM/TSP and the
proviral load in the cerebral spinal fluid (CSF) [25]. Lezin et al.
reported that the proviral load quantified in CSF was able to
distinguish clearly between healthy groups of HTLV-1 carriers
and patients presenting HAM/TSP [25].
Finally, for the first time, a high prevalence of skin disorders
(76%) independent of clinical status was disclosed among HTLV-
1-infected individuals. These findings may have important
implications in the clinical setting in places where this infection
is endemic and dermatologists, infectious diseases specialists and
general clinicians should be aware of skin presentations of the
HTLV-1 infection. Moreover, the influences of demography and
co-morbid conditions may be relevant, but have not been fully
studied. Thus, data derived from a cohort of referred patients
followed in a specialized HTLV clinic may not be a representative
sample of the whole population of HTLV-1 patients and therefore
unlikely to reflect the prevalence of skin conditions among all
HTLV-1 patients.
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